Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Lupin ropes in Jon Stelzmiller to head US specialty business

      Lupin ropes in Jon Stelzmiller to head US specialty business

      Medical Dialogues Bureau26 Sept 2019 4:54 PM IST
      New Delhi: Homegrown pharma major Lupin on Wednesday announced appointment of Jon Stelzmiller as the President of its US specialty business....
      GSK decides to recall antacid Zinetac over safety concern

      GSK decides to recall antacid Zinetac over safety concern

      Medical Dialogues Bureau26 Sept 2019 4:54 PM IST
      New Delhi: GlaxoSmithKline Pharmaceuticals Ltd on Wednesday announced recall of ranitidine hydrochloride tablets produced in India using API sourced...
      Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

      Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

      Medical Dialogues Bureau26 Sept 2019 4:54 PM IST
      Bengaluru,: Onco.com, India's only internet aggregator for cancer care, announced completion of $7 million in series A funding by Accel, Chiratae...
      Biocon subsidiary acquires Chennai-based biological research facility from Pfizer Healthcare

      Biocon subsidiary acquires Chennai-based biological research facility from Pfizer Healthcare

      Medical Dialogues Bureau26 Sept 2019 2:08 PM IST
      Biotechnology major Biocon on Tuesday said its subsidiary has acquired a Chennai-based biological research facility from Pfizer Healthcare for an...
      Alembic JV Aleor Derma gets 1 USFDA observation for Karakhadi facility

      Alembic JV Aleor Derma gets 1 USFDA observation for Karakhadi facility

      Medical Dialogues Bureau25 Sept 2019 1:53 PM IST
      Aleor Derma's formulation manufacturing facility located at Karakhadi, Gujarat got one observation after the completion of USFDA inspection. The...
      Zydus Cadila: USFDA classifies Ankleshwar facility as No Action Indicated

      Zydus Cadila: USFDA classifies Ankleshwar facility as No Action Indicated

      Medical Dialogues Bureau25 Sept 2019 9:45 AM IST
      The US Food and Drug Administration (USFDA) had conducted an inspection at the facility from July 22-26, 2019. The EIR report stated that the...
      Anuh Pharma successfully clears USFDA inspection

      Anuh Pharma successfully clears USFDA inspection

      Medical Dialogues Bureau25 Sept 2019 9:30 AM IST
      "We are pleased to inform you that a successful accomplishment at Anuh Pharma Ltd. was inspected by USFDA (United States Food and Drug Administration)...
      Cipla employee settles case with SEBI, pays Rs 3 lakh

      Cipla employee settles case with SEBI, pays Rs 3 lakh

      Medical Dialogues Bureau25 Sept 2019 9:25 AM IST
      SEBI, during its preliminary examination, observed that there was a delay on the part of Pathak in making a disclosure to the company under SEBI's PIT...
      Lupin Tarapur API facility gets 3 observations from USFDA

      Lupin Tarapur API facility gets 3 observations from USFDA

      Medical Dialogues Bureau24 Sept 2019 9:45 AM IST
      The inspection of the Tarapur facility was carried out by the US health regulator between September 16 to September 20, 2019, said Lupin.Mumbai:...
      Indoco Remedies sterile manufacturing plant in Goa gets 2 observations from UK-MHRA

      Indoco Remedies sterile manufacturing plant in Goa gets 2 observations from UK-MHRA

      Medical Dialogues Bureau24 Sept 2019 9:17 AM IST
      'The successful closure of the MHRA inspection is encouraging and reflects the immense learning and adaption by our technical team. The Sterile...
      CCI approves sale, restructuring of Apollo Pharmacy

      CCI approves sale, restructuring of Apollo Pharmacy

      Medical Dialogues Bureau24 Sept 2019 9:15 AM IST
      NEW DELHI: The Competition Commission on Monday said it has approved the restructuring of Apollo Hospitals Enterprise Ltd's pharmacy business and its...
      Novo Nordisk wins USFDA nod for oral diabetes drug Rybelsus

      Novo Nordisk wins USFDA nod for oral diabetes drug Rybelsus

      Medical Dialogues Bureau23 Sept 2019 2:16 PM IST
      Novo Nordisk did not disclose what it plans to charge for the new oral treatment, called Rybelsus, but said it would be "competitively priced" with...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok